Empagliflozin is increasingly used in patients with heart failure, with or without diabetes.
Pharmac criteria for Empagliflozin for heart failure is in short include
Heart failure - NYHA II, III, IV
On optimal standard HF treatment
Echo - LVEF <= 40%; or if not practical
Ketoacidosis risk is real, however, and sick day plan may be useful
Sick day plan trigger =
feel unwell (e.g. fever or stomach bug)
cannot eat or drink normally
Sick day plan =
Stop taking Empagliflozin
Watch for sign of dehydration
Restart after feeling better and eating/drinking normally for 2 days
We have a role in communicating such plan to patients on Empagliflozin, and is unique to the standard mix of heart failure patients.

Quisque iaculis facilisis lacinia. Mauris euismod pellentesque tellus sit amet mollis.